SG/PUT/PFIZER INC/30/0.1/20.12.24 Stock

DE000SU27315

Market Closed - Boerse Frankfurt Warrants 15:42:29 2024-07-05 EDT
0.3 ^EUR	0.00%

Current month	-6.45%
1 month	+26.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart PFIZER, INC.

Latest news about PFIZER, INC.

Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	07-05	MT
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	07-05	MT
Pfizer: former State Street CEO joins board	07-05	CF
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Management	07-05	CI

More news

Quotes 5-day view

Date	Price	Change
24-07-05	0.29	-3.33%
24-07-04	0.3	-6.25%
24-07-03	0.32	+3.23%
24-07-02	0.31	+6.90%
24-07-01	0.29	-6.45%

Real-time Boerse Frankfurt Warrants

Last update July 05, 2024 at 03:42 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	PUT
Underlying	PFIZER, INC.
Issuer	Société Générale
WKN	SU2731
ISIN	DE000SU27315
Date issued	2023-12-05
Strike	30 $
Maturity	2024-12-20 (168 Days)
Parity	10 : 1
Emission price	0.36 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.53 €
Lowest since issue	0.22 €
Spread	0.01 €
Spread %	3.33%

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

More about the company